Comparison of blood plasma protein expression in mild, moderate, and severe COVID-19 identifies novel disease severity biomarkers

AI background business technology, digital transformation

Researchers evaluated blood plasma proteins to identify new targets for COVID-19 treatment approaches and prevent complications associated with severe illness.

Netflix’s official ‘Harry and Meghan’ trailer is here and it does not hold back

Previous article

Using Big Data for Monitoring Network Design and Beyond

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News